Cardiovascular, ophthalmologic and otolaryngologic medical device innovations – Progress report 2021 from the Twenty20 consortium RESPONSE

Current Directions in Biomedical Engineering

Grabow Niels¹  Schmitz Klaus-Peter²  Senz Volkmar³ 

[1] Institute for Biomedical Engineering, University Medical Center Rostock, Friedrich-Barnewitz-Str. 4, 18119Rostock, Germany;Institute for Biomedical Engineering, University Medical Center Rostock, and Institute for ImplantTechnology and Biomaterials e.V.,Warnemuende, Germany;Institute for Biomedical Engineering, University Medical CenterRostock, Germany;

关键词: implant;    combination product;    stent;    heart valve;    glaucoma;    eustachian tube;    cochlea;    fallopian tube;    pancreas;   

DOI  :  10.1515/cdbme-2021-2181

来源: DOAJ

【 摘 要 】

The coordinated research project “RESPONSE - Partnership for Innovation in Implant Technology”, which is one of ten BMBF-funded research consortia within the program “Twenty20 - Partnership for Innovation”, is active in the field of medical device innovation. The consortium is currently in the process of unfolding its transfer phase. This involves a portfolio of key innovations for novel medical devices, technologies and processes. Also, RESPONSE is aiming at participative technology development, integrating perspectives of patients, developers, as well as systems and innovation researchers. Particular challenges are arising from the current re-prioritization and re-scheduling of project roadmaps in order to manage and alleviate the effects of the corona crisis.

【 授权许可】

Unknown